trending Market Intelligence /marketintelligence/en/news-insights/trending/yrP0LzBQV2LI4B9DiwYwVQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Sanofi execs, Philippine officials face criminal charges over Dengvaxia

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Sanofi execs, Philippine officials face criminal charges over Dengvaxia

The former president of Philippines Benigno Aquino III and former government officials, as well as Sanofi executives, are facing charges relating to a vaccination program involving Sanofi's dengue vaccine Dengvaxia, CNN Philippines reported.

The news agency stated that more than 70 mothers with children who were vaccinated filed for criminal prosecution and asked the high court to force the departments of health, education, and interior and local government to provide long-term consultations and treatment for children who received the vaccine in 2016.

Apart from Aquino, charges were also placed against the former department of health chief Janette Garin, two other government officials, Sanofi CEO Olivier Brandicourt, Sanofi Asia-Pacific Head Thomas Triomphe and three other Sanofi executives, The Philippine Star reported.

The complaint states that the defendants must be held liable for violations of the Anti-Graft and Corrupt Practices Act.

Previously, the Philippine government launched an investigation after the French drugmaker revealed Dengvaxia could worsen the disease in people not previously infected.

Sanofi spokesperson Jack Cox said the company has not directly seen the complaint and noted that the company has acted according to Philippine laws and regulations to supply and sell the vaccine according to the approved indication, Fierce Pharma reported, citing an emailed response.

Cox said the company will work cooperatively with health authorities in the Philippines to answer any additional questions.